Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,765 | 13 | 30.3% |
| Honoraria | $36,500 | 14 | 25.3% |
| Consulting Fee | $23,569 | 10 | 16.3% |
| Travel and Lodging | $22,522 | 54 | 15.6% |
| Food and Beverage | $12,151 | 329 | 8.4% |
| Compensation for serving as faculty or as a speaker for a medical education program | $4,074 | 1 | 2.8% |
| Unspecified | $1,569 | 9 | 1.1% |
| Education | $173.99 | 5 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $49,883 | 157 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $44,801 | 51 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $22,229 | 26 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $11,385 | 39 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $4,455 | 22 | $0 (2024) |
| Chiesi USA, Inc. | $3,007 | 4 | $0 (2023) |
| Fisher & Paykel Healthcare Inc | $2,269 | 7 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,854 | 8 | $0 (2024) |
| SANOFI US SERVICES INC. | $1,569 | 9 | $0 (2023) |
| ZOLL Respicardia, Inc. | $661.98 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $75,451 | 148 | Avadel CNS Pharmaceuticals, LLC ($43,180) |
| 2023 | $46,826 | 125 | JAZZ PHARMACEUTICALS INC. ($18,271) |
| 2022 | $13,257 | 47 | JAZZ PHARMACEUTICALS INC. ($9,767) |
| 2021 | $5,614 | 50 | HARMONY BIOSCIENCES LLC ($2,817) |
| 2020 | $2,221 | 29 | Jazz Pharmaceuticals Inc. ($1,790) |
| 2019 | $683.52 | 24 | JAZZ PHARMACEUTICALS INC. ($531.44) |
| 2018 | $190.72 | 6 | Jazz Pharmaceuticals Inc. ($179.04) |
| 2017 | $81.49 | 6 | Astellas Pharma US Inc ($15.54) |
All Payment Transactions
435 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Insomnia | ||||||
| 12/12/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 12/11/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: NEUROLOGY | ||||||
| 12/10/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: NEUROLOGY | ||||||
| 12/09/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Neurology | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $35.93 | General |
| Category: Immunology | ||||||
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,392.50 | General |
| Category: Insomnia | ||||||
| 11/25/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $155.44 | General |
| Category: Insomnia | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Honoraria | Cash or cash equivalent | $3,800.00 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Travel and Lodging | In-kind items and services | $552.96 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Travel and Lodging | In-kind items and services | $257.09 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/21/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $97.38 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/20/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $8.95 | General |
| Category: Insomnia | ||||||
| 11/19/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $34.68 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: NEUROLOGY | ||||||
| 11/13/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $1.63 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Neurology | ||||||
| 11/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: NEUROLOGY | ||||||
| 11/06/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Consulting Fee | Cash or cash equivalent | $239.50 | General |
| Category: Narcoplepsy | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $102.39 | General |
| Category: Insomnia | ||||||
| 11/06/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 10/30/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $8,148.00 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $4,074.00 | General |
| Category: Narcoplepsy | ||||||
| 10/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Travel and Lodging | Cash or cash equivalent | $817.95 | General |
| Category: Narcoplepsy | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma | SANOFI US SERVICES INC. | $1,569 | 9 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 999 | 1,598 | $663,079 | $195,402 |
| 2022 | 8 | 896 | 1,384 | $584,125 | $171,060 |
| 2021 | 7 | 622 | 1,056 | $489,675 | $154,257 |
| 2020 | 10 | 579 | 931 | $430,373 | $124,514 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 639 | 1,191 | $325,143 | $103,249 | 31.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 76 | 85 | $140,165 | $37,191 | 26.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 63 | 65 | $102,050 | $27,598 | 27.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $43,264 | $11,798 | 27.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 78 | $28,704 | $9,878 | 34.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 32 | 37 | $16,761 | $3,891 | 23.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 38 | $6,992 | $1,797 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 546 | 999 | $272,727 | $84,958 | 31.2% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 63 | 75 | $123,675 | $33,735 | 27.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 62 | 64 | $100,480 | $27,045 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $35,776 | $9,401 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 58 | $21,344 | $7,432 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 63 | $11,592 | $3,595 | 31.0% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2022 | 27 | 27 | $12,231 | $3,089 | 25.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $6,300 | $1,805 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 366 | 775 | $210,047 | $73,766 | 35.1% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 70 | 80 | $130,886 | $37,409 | 28.6% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 67 | 68 | $106,760 | $29,570 | 27.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $19,136 | $5,091 | 26.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 24 | 31 | $11,408 | $4,300 | 37.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 42 | $7,615 | $2,759 | 36.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 13 | 14 | $3,822 | $1,362 | 35.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 255 | 579 | $157,171 | $46,685 | 29.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 78 | 89 | $144,690 | $40,984 | 28.3% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2020 | 58 | 59 | $91,587 | $26,259 | 28.7% |
About Dr. Laura Herpel, M.D
Dr. Laura Herpel, M.D is a Pulmonary Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1558411751.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laura Herpel, M.D has received a total of $144,324 in payments from pharmaceutical and medical device companies, with $75,451 received in 2024. These payments were reported across 435 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,765).
As a Medicare-enrolled provider, Herpel has provided services to 3,096 Medicare beneficiaries, totaling 4,969 services with total Medicare billing of $645,233. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Location Columbia, SC
- Active Since 01/11/2007
- Last Updated 03/30/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1558411751
Products in Payments
- LUMRYZ (Drug) $44,801
- XYWAV (Drug) $30,049
- QUVIVIQ (Drug) $22,229
- WAKIX (Drug) $8,014
- XYREM (Drug) $7,865
- FISHER & PAYKEL HEALTHCARE (Device) $2,149
- DUPIXENT (Biological) $1,780
- Inspire Upper Airway Stimulation System (Device) $1,537
- remede System (Device) $661.98
- Wakix (Drug) $570.66
- Sunosi (Drug) $564.73
- SUNOSI (Drug) $522.93
- Horizant (Drug) $321.20
- INSPIRE (Device) $316.70
- BELSOMRA (Drug) $226.96
- Xyrem (Drug) $179.04
- Dayvigo (Drug) $133.12
- HETLIOZ (Drug) $129.10
- BREZTRI (Drug) $125.00
- 400476/Simplus Full Face Mask- Medium (Device) $119.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Columbia
Dr. Richard Bogan, M.d, M.D
Pulmonary Disease — Payments: $1.2M
Dr. Carlton Cauthen, M.d, M.D
Pulmonary Disease — Payments: $116,511
Mr. Mark Mayson, Md, MD
Pulmonary Disease — Payments: $49,937
Edward Schaefer, Md, MD
Pulmonary Disease — Payments: $16,280
Jason Goodin, D.o, D.O
Pulmonary Disease — Payments: $14,722
Yuji Oba, M.d, M.D
Pulmonary Disease — Payments: $14,418